Allgemeine Übersicht der gebräuchlichsten injizierbaren Weichgewebsfüller zur initialen Faltenbehandlung des Gesichts

Zusammenfassung

Zur initialen Faltenbehandlung des alternden Gesichts befinden sich auf dem Markt eine Vielzahl von unterschiedlichen injizierbaren Materialien. Sie unterscheiden sich in ihrer Gewebereaktion und eignen sich nicht universell für alle Gewebszonen. Neben den körpereigenen und damit sichersten biologischen Materialien, wie z. B. Eigenfett und Eigenkollagenen lassen sich Falten auch durch injizierbare nicht körpereigene biologische und synthetische Produkte korrigieren, wobei allerdings mit Nebenwirkungen wie Entzündungsreaktionen, allergischen Reaktionen, Implantatwanderung bis hin zum Implantatverlust und unerwünschtem Implantatverhalten zu rechnen ist. In einer Übersicht werden einige häufig in der Praxis angewandte injizierbare Weichgewebsfüller zur initialen Faltenbehandlung des alternden Gesichts vorgestellt und ihre Wirkung und Nebenwirkungen beschrieben.

Abstract

Injectable fillers for facial soft tissue enhancement have been developed and used for decades for the correction of age related folds and wrinkles. Many of the disadvantages of xenogenic and prior exogenous materials have been overcome with the advent of autologous and synthetic alternative materials. Autologous and synthetic injectable fillers herald a new era in the treatment of the aging face. Therefore this article will give an in-depth look at the implant choice, surgical approach, and possible complications and will provide a review of current injectable fillers for age related facial soft tissue augmentation.

Schlüsselwörter

Faltenunterspritzung - Weichgewebsfüller - Kollagen - Creutzfeld-Jakob-Erkrankung - Eigenfett

Key words

injectable fillers - soft tissue augmentation - Creutzfeld Jakob disease - lipofilling

Literatur

• 1 Allen O. Response to subdermal implantation of textured microimplants in humans.  Aesthetic Plast Surg. 1992;  16 227-230
• 2 Alster T S, West T B. Human-derived and new synthetic injectable materials for soft-tissue augmentation: current status and role in cosmetic surgery.  Plast Reconstr Surg. 2000;  105 2515-2525
• 3 Bano F, Barrington J W, Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.  Int Urogynecol J Pelvic Floor Dysfunct. 2004;  16 147-150
• 4 Beran S J, Rohrich R J. The potential role of autologous injectable dermal collagen (Autologen) and cellular dermal homografts in facial soft tissue augmentation.  Aesthetic Surg J. 1997;  17 420-429
• 5 Bergeret-Galley C, Latouche X, Illouz Y G. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep.  Aesthetic Plast Surg. 2001;  25 249-255
• 6 Bigata X, Ribera M, Bielsa I, Ferrandiz C. Adverse granulomatous reaction after cosmetic dermal silicone injection.  Dermatol Surg. 2001;  27 198-200
• 7 Boss W K, Marko O. Isolagen. In: Klein AW (ed). Tissue Augmentation in Clinical Practice; Procedures and Techniques. Marcel Dekker, New York 1998; 335-347
• 8 Breiting V, Aasted A, Jorgensen A, Opitz P, Rosetzsky A. A Study on Patients Treated with Polyacrylamide Hydrogel Injection for Facial Corrections.  Aesthetic Plast Surg. 2004;  28 45-53
• 9 Campbell G L, Laudslager N, Newman J. The effect of mechanical stress on adipocyte morphology and metabolism.  Am J Cosmet Surg. 1987;  4 89-94
• 10 Cheng N X, Wang Y L, Wang J H, Zhang X M, Zhong H. Complications of breast augmentation with injected hydrophilic polyacrylamide gel.  Aesthetic Plast Surg. 2002;  26 375-382
• 11 Cheonis N. New-Fill to treat facial wasting.  Beta. 2002;  15 10-15
• 12 Coleman W P. Lipotransfer. In: Elson ML (ed). Evaluation and treatment of the aging face. Springer, New York 1995; 101-112
• 13 Coleman W P. Lipocytic dermal augmentation. In: Klein AW (ed). Tissue Augmentation in Clinical Practice; Procedures and Techniques. Marcel Dekker, New York 1998; 49-62
• 14 Coleman W P, Lawrence N, Sherman R N, Reed R J, Pinski K S. Autologous Collagen? Lipocytic dermal augmentation; A histopathologic study.  J Dermatol Surg Oncol. 1993;  19 1032-1040
• 15 Cooperman L, Michaeli D. The immunogenicity of injectable collagen. I. A 1-year prospective study.  J Am Acad Dermatol. 1984;  10 638-646
• 16 Cooperman L S, Mackinnon V, Bechler G, Pharriss B B. Injectable collagen: a six-year clinical investigation.  Aesthetic Plast Surg. 1985;  9 145-151
• 17 de Cassia Novaes W, Berg A. Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study.  Aesthetic Plast Surg. 2003;  27 376-380
• 18 DeLustro F, Smith S T, Sundsmo J, Salem G, Kincaid S, Ellingsworth L. Reaction to injectable collagen: results in animal models and clinical use.  Plast Reconstr Surg. 1987;  79 581-594
• 19 DeVore D P, Kelmen C D, Fagien S, Casson P. Autologen: Autologous, injectable dermal collagen. In: Bosniak S (ed). Ophthalmic plastic and reconstructive surgery. Saunders, Philadelphia 1996; 670-675
• 20 Dewan P A, Byard R W. Histological response to injected Polytef and Bioplastique in a rat model.  Br J Urol. 1994;  73 370-376
• 21 Eppley B L, Summerlin D J, Prevel C D, Sadove A M. Effects of a positively charged biomaterial for dermal and subcutaneous augmentation.  Aesthetic Plast Surg. 1994;  18 413-416
• 22 Ersek R A. Transplantation of purified autologous fat: a 3-year follow-up is disappointing.  Plast Reconstr Surg. 1991;  87 219-227
• 23 Ersek R A, Beisang A A. Bioplastique: a new biphasic polymer for minimally invasive injection implantation.  Aesthetic Plast Surg. 1992;  16 59-65
• 24 Ersek R A, Gregory S R, Salisbury A V. Bioplastique at 6 years: clinical outcome studies.  Plast Reconstr Surg. 1997;  100 1570-1574
• 25 Feinendegen D L, Baumgartner R W, Vuadens P, Schroth G, Mattle H P, Regli F, Tschopp H. Autologous fat injection for soft tissue augmentation in the face: a safe procedure?.  Aesthetic Plast Surg. 1998;  22 163-167
• 26 Fernandez-Acenero M J, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation.  Dermatol Surg. 2003;  29 1225-1226
• 27 Formigli L, Zecchi S, Protopapa C, Caporale D, Cammarota N, Lotti T M. Bio-Alcamid: an electron microscopic study after skin implantation.  Plast Reconstr Surg. 2004;  113 1104-1106
• 28 Fournier P F. Facial recontouring with fat grafting.  Dermatol Clin. 1990;  8 523-537
• 29 Gold M H. Fibrel.  Dermatol Clin. 1995;  13 353-361
• 30 Hanke C W. Adverse reactions to bovine collagen. In: Klein AW (ed). Tissue Augmentation in Clinical Practice; Procedures and Techniques. Marcel Dekker, New York 1998; 145-154
• 31 Hanke C W, Coleman W P. Collagen filler substances. In: Coleman WP, Hanke CW, Alt TH, Asken S (ed). Cosmetic Surgery of the Skin. B. C. Dekker, Philadelphia 1991; 89-102
• 32 Hanke C W, Higley H R, Jolivette D M, Swanson N A, Stegman S J. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant.  J Am Acad Dermatol. 1991;  25 319-326
• 33 Homicz M R, Watson D. Review of injectable materials for soft tissue augmentation.  Facial Plast Surg. 2004;  20 21-29
• 34 Hönig J F, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction.  J Craniofac Surg. 2003;  14 197-200
• 35 Illouz Y G. The fat cell “graft”: a new technique to fill depressions.  Plast Reconstr Surg. 1986;  78 122-123
• 36 Jones R J, Schwartz B M, Silverstein P. Use of a nonimmunogenic acellular dermal allograft for soft tissue augmentation: A preliminary report.  Aesthetic Surg Q. 1996;  16 196-199
• 37 Jost G. Experience with collagen injection for the correction of contour deficiencies.  Aesthetic Plast Surg. 1985;  9 163-165
• 38 Klein A W. Indications and implantation techniques for the various formulations of injectable collagen.  J Dermatol Surg Oncol. 1988;  14 (Suppl 1) 27-30
• 39 Klein A W. Injectable Collagen. In: Moschella SL, Hurley HJ (eds). Dermatology. Saunders, Philadelphia 1992; 2455-2457
• 40 Klein A W. Granulomatous foreign body reaction against hyaluronic acid.  Dermatol Surg. 2004;  30 1070
• 41 Klein A W, Wexler P, Carruthers A, Carruthers J. Treatment of facial furrows and rhytides.  Dermatol Clin. 1997;  15 595-607
• 42 Lemperle G, Hazan-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft-tissue augmentation. Part II: Clinical investigations.  Plast Reconstr Surg. 1995;  96 627-634
• 43 Lemperle G, Gauthier-Hazan N, Lemperle M. PMMA-Microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results.  Aesthetic Plast Surg. 1998;  22 356-365
• 44 Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation.  Aesthetic Plast Surg. 2003;  27 354-366
• 45 Lemperle G, Morhenn V B, Pestonjamasp V, Gallo R L. Migration studies and histology of injectable microspheres of different sizes in mice.  Plast Reconstr Surg. 2004;  113 1380-1390
• 46 Lemperle G, Ott H, Charrier U, Hecker J, Lemperle M. PMMA microspheres for intradermal implantation: Part I. Animal research.  Ann Plast Surg. 1991;  26 57-63
• 47 Livesey S A, Herndon D N, Hollyoak M A, Atkinson Y H, Nag A. Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis.  Transplantation. 1995;  60 1-9
• 48 Lombardi T, Samson J, Plantier F, Husson C, Kuffer R. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases.  J Oral Pathol Med. 2004;  33 115-120
• 49 Lupton J R, Alster T S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel.  Dermatol Surg. 2000;  26 135-137
• 50 McClelland M, Egbert B, Hanko V, Berg R A, DeLustro F. Evaluation of artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization.  Plast Reconstr Surg. 1997;  100 1466-1474
• 51 Mladick R A. Twelve months of experience with Bioplastique.  Aesthetic Plast Surg. 1992;  16 69-76
• 52 Neuber F. Fetttransplantation.  Chir Kong Verhandl Dsch Gesellsch Chir. 1893;  22 66
• 53 Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds.  Aesthetic Plast Surg. 1998;  22 97-101
• 54 Overholt M A, Tschen J A, Font R L. Granulomatous reaction to collagen implant: light and electron microscopic observations.  Cutis. 1993;  51 95-98
• 55 Pacini S, Ruggiero M, Cammarota N, Protopapa C, Gulisano M. Bio-Alcamid, a novel prosthetic polymer, does not interfere with morphological and functional characteristics of human skin fibroblasts.  Plast Reconstr Surg. 2003;  111 489-491
• 56 Pacini S, Ruggiero M, Morucci G, Cammarota N, Protopapa C, Gulisano M. Bio-alcamid: a novelty for reconstructive and cosmetic surgery.  Ital J Anat Embryol. 2002;  107 209-214
• 57 Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft-tissue augmentation implant material.  J Am Acad Dermatol. 1997;  36 544-549
• 58 Piacquadio D, Larsen N E, Denlinger J L, Balazs E A. Hylan B gel (Hylaform) as a soft tissue augmentation material. In: Klein AW (ed). Tissue Augmentation in Clinical Practice; Procedures and Techniques. Marcel Dekker, New York 1998; 269-291
• 59 Pieyre J M. Collagen injections: two years' experience.  Aesthetic Plast Surg. 1985;  9 153-154
• 60 Pinski K S, Roenigk H H. Autologous fat transplantation. Long-term follow-up.  J Dermatol Surg Oncol. 1992;  18 179-184
• 61 Protopapa C, Sito G, Caporale D, Cammarota N. Bio-Alcamid in drug-induced lipodystrophy.  J Cosmet Laser Ther. 2003;  5 226-230
• 62 Rongioletti F, Cattarini G, Sottofattori E, Rebora A. Granulomatous reaction after intradermal injections of hyaluronic acid gel.  Arch Dermatol. 2003;  139 815-816
• 63 Saray A. Porcine dermal collagen (Permacol) for facial contour augmentation: preliminary report.  Aesthetic Plast Surg. 2003;  27 368-375
• 64 Sclafani A P, Romo T. Injectable fillers for facial soft tissue enhancement.  Facial Plast Surg. 2000;  16 29-34
• 65 Sclafani A P, Romo T, Jacono A A. Rejuvenation of the aging lip with an injectable acellular dermal graft (Cymetra).  Arch Facial Plast Surg. 2002;  4 252-257
• 66 Senet P, Bachelez H, Ollivaud L, Vignon-Pennamen D, Dubertret L. Minocycline for the treatment of cutaneous silicone granulomas.  Br J Dermatol. 1999;  140 985-987
• 67 Simons G, Mazaleyrat P, Masurel T. Utilization of injectable microimplants in aesthetic facial surgery.  Aesthetic Plast Surg. 1992;  16 77-82
• 68 Sklar J A, White S M. Radiance FN: a new soft tissue filler.  Dermatol Surg. 2004;  30 764-768
• 69 Spenlehauer G, Vert M, Benoit J P, Boddaert A. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method.  Biomaterials. 1989;  10 557-563
• 70 Tobin H A, Karas N D. Lip augmentation using an alloderm graft.  J Oral Maxillofac Surg. 1998;  56 722-727
• 71 Tolleth H. Long-term efficacy of collagen.  Aesthetic Plast Surg. 1985;  9 155-158
• 72 Valantin M A, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.  Aids. 2003;  17 2471-2477
• 73 Wainwright D J. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns.  Burns. 1995;  21 243-248
• 74 Watson D, Keller G S, Lacombe V, Fodor P B, Rawnsley J, Lask G P. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study.  Arch Facial Plast Surg. 1999;  1 165-170
• 75 Webster R C, Gaunt J M, Hamdan U S, Fuleihan N S, Smith R C. Injectable silicone for facial soft-tissue augmentation.  Arch Otolaryngol Head Neck Surg. 1986;  112 290-296
• 76 West T B, Alster T S. Autologous human collagen and dermal fibroblasts for soft tissue augmentation.  Dermatol Surg. 1998;  24 510-512